Skip to content
Assyro AI
FDA 483 Database

FDA Form 483s Issued in November 2023

Every published Form FDA 483 issued in November 2023, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

9

Published 483s in November 2023

9

Distinct firms

Form 483s issued in November 2023

  • Jiangsu Intco Medical Products Co., Ltd.FDA
    FEI
    3005260401
    Record date
    Establishment
    OTC Drug Manufacturer
    Location
    China
  • Daizo CorporationFDA
    FEI
    3008470621
    Record date
    Establishment
    OTC Drug Manufacturer
    Location
    Japan
  • Takeda Pharmaceutical Company LimitedFDA
    FEI
    3004664162
    Record date
    Establishment
    Human Drug Manufacturer
    Location
    Japan
  • Nanchang Anobri Pharmaceutical Co., Ltd.FDA
    FEI
    3023765884
    Record date
    Establishment
    Finished Pharmaceutical Manufacturer
    Location
    China
  • C&T Dream Co., Ltd.FDA
    FEI
    3012668529
    Record date
    Establishment
    Finished Pharmaceutical Manufacturer
    Location
    Republic of Korea
  • Contract Pharmaceuticals Limited CanadaFDA
    FEI
    3001581899
    Record date
    Establishment
    Finished Pharmaceutical Manufacturer
    Location
    Canada
  • Catalent Indiana, LLCFDA
    FEI
    3005949964
    Record date
    Establishment
    Manufacturer
    Location
    Indiana, United States
  • Wedgewood Connect, LLCFDA
    FEI
    3003434972
    Record date
    Establishment
    Outsourcing Facility
    Location
    California, United States
  • Hybrid Pharma LLCFDA
    FEI
    3011319445
    Record date
    Establishment
    Outsourcing Facility
    Location
    Florida, United States

Other months in 2023

Back to the FDA 483 Database